Advance in the Diagnostics and Management of Dementia
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 484
Special Issue Editor
Special Issue Information
Dear Colleagues,
The clinical differentiation between various neurodegenerative disorders that cause cognitive impairment and dementia can be challenging, particularly at early disease stages or when the presentation is atypical. That is also true for predicting the fate of patients in terms of disease progression and response to treatment. There is great demand for diagnostic tools that can accurately distinguish patients with symptomatic dementia from those with mild cognitive impairment and normal cognition, and for tools that can predict progressive disease using relatively inexpensive and accessible inputs.
We encourage the submission of original research and review articles on novel diagnostic techniques for all kinds of dementia disorders, encompassing (but not limited to) medical imaging, molecular diagnostics, CSF and blood biomarkers, neuropathology and advanced machine learning methods for the diagnosis and risk stratification of dementia continuum.
Dr. Liam L. Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dementia
- neurodegeneration
- neuropathology
- radiology
- nuclear medicine
- optical diagnostics
- molecular diagnostics
- CSF and blood biomarkers
- artificial intelligence
- applied machine learning
- aging
- microglia
- Alzheimer’s disease
- tauopathy
- Huntington’s disease
- α-synucleinopathy
- Parkinson’s disease dementia
- dementia with Lewy bodies
- TDP-43 proteinopathy
- frontotemporal dementia
- amyotrophic lateral sclerosis
- chronic traumatic encephalopathy
